When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HIMS - Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder
Hims & Hers Health Inc. Class A
2025-07-16 08:45:00 ET
Hims & Hers Health (NYSE: HIMS) is a top telehealth stock that has been growing its business rapidly in recent years. And one of the ways it has done that is by expanding into new markets and reaching a broader range of customers.
Recently, it's looking to take advantage of an opportunity that has opened up as a result of a costly mistake that drugmaker Novo Nordisk (NYSE: NVO) has made. After failing to pay a maintenance fee, the patent on semaglutide will run out in Canada as early as next year. And Hims & Hers is looking to capitalize on that.